{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:16:59Z","timestamp":1789395419805,"version":"build-2803163510"},"reference-count":68,"publisher":"American Chemical Society (ACS)","issue":"17","license":[{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci?n y Universidades","doi-asserted-by":"publisher","award":["PID2021-126423OB-C22"],"award-info":[{"award-number":["PID2021-126423OB-C22"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci?n y Universidades","doi-asserted-by":"publisher","award":["PID2022-138788NB-I00"],"award-info":[{"award-number":["PID2022-138788NB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci?n y Universidades","doi-asserted-by":"publisher","award":["PID2024-160392OB-C22"],"award-info":[{"award-number":["PID2024-160392OB-C22"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cient?ficas","doi-asserted-by":"publisher","award":["202580E109"],"award-info":[{"award-number":["202580E109"]}],"id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The mineralocorticoid receptor (MR), a member of the steroid hormone nuclear receptor subfamily, mediates the effects of aldosterone and glucocorticoids. Initially characterized in epithelial tissues as a key regulator of blood pressure, MR was later found to be widely expressed across multiple tissues, where it mediates processes such as inflammation, oxidative stress, and fibrosis. Accordingly, MR antagonists (MRAs) have important clinical applications beyond their diuretic effect, forming a cornerstone in the treatment of chronic heart failure and showing promise in conditions like diabetic nephropathy. Nonsteroidal MRAs typically show fewer off-target effects than their steroidal counterparts, although the risk of hyperkalemia\u2500especially in patients with renal impairment\u2500remains a concern. A detailed understanding of MRA-binding modes is therefore crucial for the development of improved therapeutics. To this end, we conducted an extensive computational study integrating induced fit docking (IFD) and molecular dynamics (MD) simulations across a comprehensive set of MRAs. This approach highlights key interactions responsible for binding affinity and offers insights into the molecular basis of selectivity and antagonism. Moreover, MD simulations revealed a potential link between the ligand interaction with Trp806 and coregulator recruitment. These findings provide a valuable foundation for in silico rational design of next-generation MRAs with enhanced safety and efficacy profiles.<\/jats:p>","DOI":"10.1021\/acs.jcim.6c00183","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T15:01:33Z","timestamp":1786806093000},"page":"11140-11162","source":"Crossref","is-referenced-by-count":0,"title":["In Silico Decoding\nof Nonsteroidal Mineralocorticoid\nReceptor Antagonist Binding: Implications for Drug Design"],"prefix":"10.1021","volume":"66","author":[{"given":"Felipe","family":"Pe\u0301rez-Gordillo","sequence":"first","affiliation":[{"name":"Instituto de Qui\u0301mica Me\u0301dica (IQM-CSIC) , Juan de la Cierva 6 , ,","place":["Madrid, Spain, 28006"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laureano E.","family":"Carpio","sequence":"additional","affiliation":[{"name":"MolDrug AI Systems SL, Parque Tecnolo\u0301gico de Valencia , ,","place":["Valencia, Spain, 46980"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4324-2793","authenticated-orcid":true,"given":"Diego","family":"Alvarez de la Rosa","sequence":"additional","affiliation":[{"name":"Universidad de La Laguna , ,","place":["La Laguna, Spain, 382000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6449-0905","authenticated-orcid":true,"given":"Mercedes","family":"Marti\u0301n-Marti\u0301nez","sequence":"additional","affiliation":[{"name":"Instituto de Qui\u0301mica Me\u0301dica (IQM-CSIC) , Juan de la Cierva 6 , ,","place":["Madrid, Spain, 28006"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,15]]},"reference":[{"issue":"Suppl","key":"2026091409065554300_cit1","doi-asserted-by":"publisher","first-page":"S223","DOI":"10.1111\/bph.16179","article-title":"The Concise Guide to PHARMACOLOGY 2023\/24: Nuclear\nHormone Receptors","volume":"180","author":"Alexander","year":"2023","journal-title":"Br. J. Pharmacol."},{"issue":"13","key":"2026091409065554300_cit2","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1111\/bph.15746","article-title":"Structural\nand Molecular Determinants of Mineralocorticoid Receptor Signalling","volume":"179","author":"Grossmann","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"2026091409065554300_cit3","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","article-title":"11beta-Hydroxysteroid Dehydrogenases:\nIntracellular Gate-Keepers of Tissue Glucocorticoid Action","volume":"93","author":"Chapman","year":"2013","journal-title":"Physiol. Rev."},{"issue":"3","key":"2026091409065554300_cit4","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/cphy.c130044","article-title":"The Multifaceted Mineralocorticoid\nReceptor","volume":"4","author":"Gomez-Sanchez","year":"2014","journal-title":"Compr. Physiol."},{"issue":"1","key":"2026091409065554300_cit5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1124\/pr.115.011106","article-title":"Emerging Roles of the Mineralocorticoid\nReceptor in\nPathology: Toward New Paradigms in Clinical Pharmacology","volume":"68","author":"Jaisser","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"2026091409065554300_cit6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/FJC.0000000000000329","article-title":"Third-Generation\nMineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?","volume":"67","author":"Gomez-Sanchez","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"2026091409065554300_cit7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1146\/annurev-physiol-060821-013950","article-title":"Roles of Mineralocorticoid\nReceptors\nin Cardiovascular and Cardiorenal Diseases","volume":"84","author":"Barrera-Chimal","year":"2022","journal-title":"Annu. Rev. Physiol."},{"issue":"13","key":"2026091409065554300_cit8","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1111\/bph.15708","article-title":"Mineralocorticoid\nReceptor in Cardiovascular\nDiseases-Clinical Trials and Mechanistic Insights","volume":"179","author":"Bauersachs","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"2026091409065554300_cit9","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1111\/bph.15808","article-title":"Emerging Fields for Therapeutic Targeting\nof the Aldosterone-Mineralocorticoid Receptor Signaling Pathway","volume":"179","author":"Lother","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"13","key":"2026091409065554300_cit10","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1111\/bph.15835","article-title":"Brain Mineralocorticoid\nReceptor in Health and Disease: From Molecular Signalling to Cognitive\nand Emotional Function","volume":"179","author":"Paul","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"2026091409065554300_cit11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.119.13569","article-title":"Double-Blind Randomized\nPhase 3 Study Comparing Esaxerenone\n(CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN\nStudy)","volume":"75","author":"Ito","year":"2020","journal-title":"Hypertension"},{"key":"2026091409065554300_cit12","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.88417","article-title":"Advances\nin the Development of Non-Steroidal Mineralocorticoid-Receptor Antagonists","volume-title":"Aldosterone-Mineralocorticoid Receptor - Cell Biology\nto Translational Medicine","author":"Pe\u0301rez-Gordillo","year":"2019"},{"issue":"7","key":"2026091409065554300_cit13","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1021\/acs.jmedchem.6b01065","article-title":"Modulating Mineralocorticoid Receptor with Non-Steroidal\nAntagonists. New Opportunities for the Development of Potent and Selective\nLigands without Off-Target Side Effects","volume":"60","author":"Marti\u0301n-Marti\u0301nez","year":"2017","journal-title":"J.\nMed. Chem."},{"issue":"35","key":"2026091409065554300_cit14","doi-asserted-by":"publisher","first-page":"31283","DOI":"10.1074\/jbc.M504098200","article-title":"A Ligand-Mediated Hydrogen Bond Network\nRequired for the Activation of the Mineralocorticoid Receptor","volume":"280","author":"Bledsoe","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"6","key":"2026091409065554300_cit15","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nsmb939","article-title":"Crystal Structure of a Mutant Mineralocorticoid Receptor\nResponsible for Hypertension","volume":"12","author":"Fagart","year":"2005","journal-title":"Nat. Struct. Mol.\nBiol."},{"issue":"3","key":"2026091409065554300_cit16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.molcel.2005.06.026","article-title":"Structural and Biochemical\nMechanisms for the Specificity of Hormone Binding and Coactivator\nAssembly by Mineralocorticoid Receptor","volume":"19","author":"Li","year":"2005","journal-title":"Mol.\nCell"},{"issue":"3","key":"2026091409065554300_cit17","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4890","article-title":"The Mineralocorticoid\nReceptor Forms Higher Order Oligomers upon DNA Binding","volume":"33","author":"Fettweis","year":"2024","journal-title":"Protein Sci."},{"issue":"3","key":"2026091409065554300_cit18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and Ligand Preparation: Parameters,\nProtocols,\nand Influence on Virtual Screening Enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided. Mol. Des."},{"issue":"7","key":"2026091409065554300_cit19","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide:\nA New Approach for Rapid, Accurate Docking and Scoring. 1. Method\nand Assessment of Docking Accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med.\nChem."},{"issue":"7","key":"2026091409065554300_cit20","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"A New Approach for Rapid, Accurate\nDocking and Scoring. 2. Enrichment Factors in Database Screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"24","key":"2026091409065554300_cit21","doi-asserted-by":"publisher","first-page":"8616","DOI":"10.1021\/jm2011645","article-title":"Identification of Benzoxazin-3-One\nDerivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid\nReceptor Antagonists","volume":"54","author":"Hasui","year":"2011","journal-title":"J. Med. Chem."},{"issue":"19","key":"2026091409065554300_cit22","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1016\/j.bmc.2013.07.043","article-title":"Design, Synthesis,\nand Structure\u2013Activity\nRelationships of Dihydrofuran-2-One and Dihydropyrrol-2-One Derivatives\nas Novel Benzoxazin-3-One-Based Mineralocorticoid Receptor Antagonists","volume":"21","author":"Hasui","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"19","key":"2026091409065554300_cit23","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.1016\/j.bmc.2014.07.038","article-title":"Discovery of 6-[5-(4-Fluorophenyl)-3-Methyl-Pyrazol-4-Yl]-Benzoxazin-3-One\nDerivatives as Novel Selective Nonsteroidal Mineralocorticoid Receptor\nAntagonists","volume":"22","author":"Hasui","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"2026091409065554300_cit24","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.bmc.2016.02.014","article-title":"Identification\nof Spirooxindole and Dibenzoxazepine Motifs as Potent Mineralocorticoid\nReceptor Antagonists","volume":"24","author":"Lotesta","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"2026091409065554300_cit25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/cmdc.201600529","article-title":"Structure-Based Drug Design of Mineralocorticoid\nReceptor Antagonists to Explore Oxosteroid Receptor Selectivity","volume":"12","author":"Nordqvist","year":"2017","journal-title":"ChemMedChem"},{"issue":"1","key":"2026091409065554300_cit26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1747-0285.2005.00327.x","article-title":"Use of an Induced Fit Receptor Structure\nin Virtual Screening","volume":"67","author":"Sherman","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"issue":"2","key":"2026091409065554300_cit27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel Procedure for\nModeling Ligand\/Receptor Induced Fit Effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"issue":"3","key":"2026091409065554300_cit28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0022-2836(02)00470-9","article-title":"On the Role of the\nCrystal Environment in Determining Protein Side-Chain Conformations","volume":"320","author":"Jacobson","year":"2002","journal-title":"J. Mol. Biol."},{"issue":"2","key":"2026091409065554300_cit29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A Hierarchical Approach\nto All-Atom\nProtein Loop Prediction","volume":"55","author":"Jacobson","year":"2004","journal-title":"Proteins"},{"key":"2026091409065554300_cit30","unstructured":"Case, D. A.; Aktulga, H. M.; Belfon, K.; Ben-Shalom, I. Y.; Berryman, J. T.; Brozell, S. R.; Cerutti, D. S.; Cheatham, T. E.; Cisneros, G. A.; Cruzeiro, V. W. D.; Darden, T. A.; Duke, R. E.; Giambasu, G.; Gilson, M. K.; Gohlke, H.; Goetz, A. W.; Harris, R.; Izadi, S.; Izmailov, S. A.; Kasavajhala, K.; Kaymak, M. C.; King, E.; Kovalenko, A.; Kurtzman, T.; Lee, T. S.; LeGrand, S.; Li, P.; Lin, C.; Liu, J.; Luchko, T.; Luo, R.; Machado, M.; Man, V.; Manathunga, M.; Merz, K. M.; Miao, Y.; Mikhailovskii, O.; Monard, G.; Nguyen, H.; Onufriev, A.; Pan, F.; Pantano, S.; Qi, R.; Rahnamoun, A.; Roe, D. R.; Roitberg, A.; Sagui, C.; Schott-Verdugo, S.; Shajan, A.; Shen, J.; Simmerling, C. L.; Skrynnikov, N. R.; Smith, J.; Swails, J.; Walker, R. C.; Wang, J.; Wang, J.; Wei, H.; Wolf, R. M.; Wu, X.; Xiong, Y.; Xue, Y.; York, D. M.; Zhao, S.; Kollman, P. A.\n          AMBER; University of California: San Francisco, 2020."},{"issue":"2","key":"2026091409065554300_cit31","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison\nof Simple Potential Functions for Simulating Liquid Water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"2026091409065554300_cit32","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/molecules30061226","article-title":"In Silico Investigation of Mineralocorticoid Receptor\nAntagonists: Insights into Binding Mechanisms and Structural Dynamics","volume":"30","author":"Liang","year":"2025","journal-title":"Molecules"},{"issue":"39","key":"2026091409065554300_cit33","doi-asserted-by":"publisher","first-page":"29932","DOI":"10.1074\/jbc.M110.131342","article-title":"A New Mode of Mineralocorticoid\nReceptor\nAntagonism by a Potent and Selective Nonsteroidal Molecule","volume":"285","author":"Fagart","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"16","key":"2026091409065554300_cit34","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1021\/jm100506y","article-title":"Discovery of Novel Cyanodihydropyridines\nas Potent Mineralocorticoid Receptor Antagonists","volume":"53","author":"Arhancet","year":"2010","journal-title":"J. Med. Chem."},{"issue":"10","key":"2026091409065554300_cit35","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.1021\/jm1002827","article-title":"Stereochemical Requirements for the Mineralocorticoid\nReceptor Antagonist Activity of Dihydropyridines","volume":"53","author":"Arhancet","year":"2010","journal-title":"J. Med. Chem."},{"issue":"8","key":"2026091409065554300_cit36","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/cmdc.201200081","article-title":"Discovery of BAY 94\u20138862:\nA Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the\nTreatment of Cardiorenal Diseases","volume":"7","author":"Ba\u0308rfacker","year":"2012","journal-title":"ChemMedChem"},{"issue":"3","key":"2026091409065554300_cit37","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.3390\/ijms24032439","article-title":"Novel 1,4-Dihydropyridine\nDerivatives\nas Mineralocorticoid Receptor Antagonists","volume":"24","author":"Pe\u0301rez-Gordillo","year":"2023","journal-title":"Int.\nJ. Mol. Sci."},{"issue":"12","key":"2026091409065554300_cit38","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1093\/emboj\/17.12.3317","article-title":"Antagonism\nin the Human Mineralocorticoid\nReceptor","volume":"17","author":"Fagart","year":"1998","journal-title":"EMBO J."},{"issue":"4","key":"2026091409065554300_cit39","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1124\/mol.58.4.684","article-title":"A Single\nAmino Acid Mutation of Ala-773 in the Mineralocorticoid Receptor Confers\nAgonist Properties to 11beta-Substituted Spirolactones","volume":"58","author":"Auzou","year":"2000","journal-title":"Mol. Pharmacol."},{"issue":"5476","key":"2026091409065554300_cit40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1126\/science.289.5476.119","article-title":"Activating Mineralocorticoid Receptor Mutation in Hypertension\nExacerbated by Pregnancy","volume":"289","author":"Geller","year":"2000","journal-title":"Science"},{"issue":"6","key":"2026091409065554300_cit41","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1210\/me.2004-0537","article-title":"The Ligand-Dependent\nInteraction of Mineralocorticoid Receptor with Coactivator and Corepressor\nPeptides Suggests Multiple Activation Mechanisms","volume":"19","author":"Hultman","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"2026091409065554300_cit42","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/1873-3468.13746","article-title":"Crystal Structure of the Mineralocorticoid Receptor\nLigand-Binding Domain in Complex with a Potent and Selective Nonsteroidal\nBlocker, Esaxerenone (CS-3150)","volume":"594","author":"Takahashi","year":"2020","journal-title":"FEBS Lett."},{"issue":"36","key":"2026091409065554300_cit43","doi-asserted-by":"publisher","first-page":"21876","DOI":"10.1074\/jbc.M115.657957","article-title":"Finerenone\nImpedes Aldosterone-Dependent Nuclear Import of the Mineralocorticoid\nReceptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1","volume":"290","author":"Amazit","year":"2015","journal-title":"J. Biol. Chem."},{"key":"2026091409065554300_cit44","doi-asserted-by":"publisher","first-page":"109291","DOI":"10.1016\/j.steroids.2023.109291","article-title":"Molecular Pharmacology of Mineralocorticoid Receptor\nAntagonists: The Role of Co-Regulators","volume":"199","author":"Koca","year":"2023","journal-title":"Steroids"},{"issue":"2","key":"2026091409065554300_cit45","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0193380","article-title":"Preclinical Pharmacology of AZD9977:\nA Novel Mineralocorticoid Receptor Modulator Separating Organ Protection\nfrom Effects on Electrolyte Excretion","volume":"13","author":"Bamberg","year":"2018","journal-title":"PLoS\nOne"},{"issue":"3","key":"2026091409065554300_cit46","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1021\/acs.jmedchem.8b01523","article-title":"Identification of Mineralocorticoid Receptor Modulators\nwith Low Impact on Electrolyte Homeostasis but Maintained Organ Protection","volume":"62","author":"Granberg","year":"2019","journal-title":"J. Med. Chem."},{"key":"2026091409065554300_cit47","unstructured":"A Phase III, Randomised, Double-Blind Study to Evaluate\nthe Effect\nof Balcinrenone\/Dapagliflozin, Compared With Dapagliflozin, on the\nRisk of Heart Failure Events and Cardiovascular Death in Patients\nWith Heart Failure and Impaired Kidney Function. (accessed\nFebruary 6, 2024). https:\/\/clinicaltrials.gov\/study\/NCT06307652."},{"key":"2026091409065554300_cit48","unstructured":"Casimiro-Garcia, A.; Futatsugi, K.; Piotrowski, D. W.\n          Morpholine Compounds as Mineralocorticoid Receptor\nAntagonists. WO2011\/141848A1, 2011. http:\/\/wo2011\/141848A1."},{"key":"2026091409065554300_cit49","unstructured":"Michellys, P. Y.; Pei, W.; Petrassi, H. M.; Richmond, W.\n          Compounds\nand\nCompositions as Modulators of Steroid Hormone Nuclear Receptors. WO2006\/015259, 2006. http:\/\/wo2006\/015259."},{"issue":"3","key":"2026091409065554300_cit50","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1254\/jphs.10285FP","article-title":"SM-368229, a Novel\nSelective and Potent Non-Steroidal\nMineralocorticoid Receptor Antagonist with Strong Urinary Na+ Excretion\nActivity","volume":"115","author":"Nariai","year":"2011","journal-title":"J. Pharmacol. Sci."},{"key":"2026091409065554300_cit51","unstructured":"Boyer, S.; Guo, X.; Wu, D.; Wu, F.\n          Pyridyl Ureas as Mineralocorticoid\nReceptor Antagonists. WO2012\/064631A1, 2012. http:\/\/wo2012\/064631A1."},{"key":"2026091409065554300_cit52","unstructured":"Coghlan, M. J.; Green, J. E.; Grese, T. A.; Jadhav, P. K.; Matthews, D. P.; Steinberg, M. I.; Fales, K. R.; Bell, M. G.\n          Tricyclic Steroid\nHormone Nuclear Receptor Modulators. WO2004\/052847A2, 2004. http:\/\/wo2004\/052847A2."},{"key":"2026091409065554300_cit53","unstructured":"Coghlan, M. J.; Jadhav, P. K.; Droste, J. J.; Green, J. E.; Matthews, D. P.\n          Tricyclic Steroid\nHormone Nuclear Receptor Modulators. WO2005\/066153A1, 2005. http:\/\/wo2005\/066153A1."},{"key":"2026091409065554300_cit54","unstructured":"Gavardinas, K.; Green, J. E.; Jadhav, P. K.; Matthews, D. P.\n          Tryciclic Steroid\nHormone Nuclear Receptor Modulators. WO2005\/066161A1, 2005. http:\/\/wo2005\/066161A1."},{"key":"2026091409065554300_cit55","unstructured":"Gavardinas, K.; Jadhav, P. K.\n          6H-Dibenzo[B,E]Oxepine Derived Nonsteroidal Mineralocorticoid\nReceptor\nAntagonist. WO2009\/085584A1, 2009."},{"key":"2026091409065554300_cit56","unstructured":"Coates, D. A.; Gavardinas, K.; Jadhav, P. K.\n          Mineralocorticoid\nReceptor Antagonist and Methods of Use. WO2010\/104721A1, 2010. http:\/\/wo2010\/104721A1."},{"key":"2026091409065554300_cit57","unstructured":"Iijima, T.; Yamamoto, Y.; Akatsuka, H.; Kawaguchi, T.\n          Benzoxazines and\nRelated Nitrogen-Containing Heterobicyclic Compounds Useful as Mineralocorticoid\nReceptor Modulating Agents. WO2007\/089034, 2007. http:\/\/wo2007\/089034."},{"issue":"9","key":"2026091409065554300_cit58","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/hepr.13695","article-title":"Efficacy and Safety of Apararenone\n(MT-3995) in Patients with Nonalcoholic Steatohepatitis: A Randomized\nControlled Study","volume":"51","author":"Okanoue","year":"2021","journal-title":"Hepatol. Res."},{"issue":"2","key":"2026091409065554300_cit59","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s10157-020-01963-z","article-title":"Apararenone\nin Patients with Diabetic\nNephropathy: Results of a Randomized, Double-Blind, Placebo-Controlled\nPhase 2 Dose\u2013Response Study and Open-Label Extension Study","volume":"25","author":"Wada","year":"2021","journal-title":"Clin. Exp. Nephrol."},{"key":"2026091409065554300_cit60","unstructured":"Apararenone - Mitsubishi Tanabe Pharma - AdisInsight. https:\/\/adisinsight.springer.com\/drugs\/800032686 (accessed 06, 17, 2022)."},{"key":"2026091409065554300_cit61","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejphar.2015.06.015","article-title":"Pharmacological\nProfile of CS-3150, a Novel, Highly Potent and Selective Non-Steroidal\nMineralocorticoid Receptor Antagonist","volume":"761","author":"Arai","year":"2015","journal-title":"Eur.\nJ. Pharmacol."},{"key":"2026091409065554300_cit62","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejphar.2015.11.028","article-title":"CS-3150, a\nNovel Non-Steroidal Mineralocorticoid\nReceptor Antagonist, Prevents Hypertension and Cardiorenal Injury\nin Dahl Salt-Sensitive Hypertensive Rats","volume":"769","author":"Arai","year":"2015","journal-title":"Eur.\nJ. Pharmacol."},{"key":"2026091409065554300_cit63","unstructured":"Katayama, S.; Hori, S.; Hasegawa, F.; Suzuki, K.\n          Biaryl\nAmide Derivative or\nPharmaceutically Acceptable Salt Thereof. U.S. Patent WO2013\/116227A1, 2013. http:\/\/us2013116227a1."},{"issue":"16","key":"2026091409065554300_cit64","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1021\/jm100505n","article-title":"Discovery of (3S,3aR)-2-(3-Chloro-4-Cyanophenyl)-3-Cyclopentyl-3,3a,4,5-Tetrahydro-2H-Benzo[g]Indazole-7-Carboxylic\nAcid (PF-3882845), an Orally Efficacious Mineralocorticoid Receptor\n(MR) Antagonist for Hypertension and Nephropathy","volume":"53","author":"Meyers","year":"2010","journal-title":"J. Med. Chem."},{"key":"2026091409065554300_cit65","unstructured":"Meyers, M. J.; Arhancet, G. B.; Chen, X.; Hockerman, S. L.; Long, S. A.; Mahoney, M. W.; Reitz, D. B.; Rico, J. G.; Long Scott, A.; Mahoney, M. W.; Reitz, D. B.; Rico, J. G.\n          Pyrazoline\nCompounds As Mineralocorticoid Receptor Antagonists. WO2008053300A1, May 8, 2008."},{"key":"2026091409065554300_cit66","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1021\/jm500206r","article-title":"Identification of (R)-6-(1-(4-Cyano-3-Methylphenyl)-5-Cyclopentyl-4,5-Dihydro-1H-Pyrazol-3-Yl)-2-Me\nThoxynicotinic Acid, a Highly Potent and Selective Nonsteroidal Mineralocorticoid\nReceptor Antagonist","volume":"57","author":"Casimiro-Garcia","year":"2014","journal-title":"J. Med. Chem."},{"key":"2026091409065554300_cit67","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/FPHAR.2013.00115","article-title":"PF-03882845,\na Non-Steroidal Mineralocorticoid Receptor Antagonist, Prevents Renal\nInjury with Reduced Risk of Hyperkalemia in an Animal Model of Nephropathy","volume":"4","author":"Orena","year":"2013","journal-title":"Front. Pharmacol."},{"key":"2026091409065554300_cit68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","article-title":"Selective Estrogen\nReceptor Modulators (SERMs) and\nSelective Estrogen Receptor Degraders (SERDs) in Cancer Treatment","volume":"186","author":"Patel","year":"2018","journal-title":"Pharmacol. Ther."}],"container-title":["Journal of Chemical Information\nand Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jcim.6c00183","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jcisd8\/article-pdf\/66\/17\/11140\/66604361\/acs.jcim.6c00183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jcisd8\/article-pdf\/66\/17\/11140\/66604361\/acs.jcim.6c00183.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:18:56Z","timestamp":1789391936000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jcisd8\/article\/66\/17\/11140\/5259292\/In-Silico-Decoding-of-Nonsteroidal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":68,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,8,15]]},"published-print":{"date-parts":[[2026,9,14]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jcim.6c00183","relation":{},"ISSN":["1549-9596","1549-960X"],"issn-type":[{"value":"1549-9596","type":"print"},{"value":"1549-960X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]}}}